CY2292B1 - Pharmaceutical compositions containing platelet aggregation inhibitors - Google Patents

Pharmaceutical compositions containing platelet aggregation inhibitors

Info

Publication number
CY2292B1
CY2292B1 CY0200051A CY0200051A CY2292B1 CY 2292 B1 CY2292 B1 CY 2292B1 CY 0200051 A CY0200051 A CY 0200051A CY 0200051 A CY0200051 A CY 0200051A CY 2292 B1 CY2292 B1 CY 2292B1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical compositions
compositions containing
platelet aggregation
aggregation inhibitors
containing platelet
Prior art date
Application number
CY0200051A
Other languages
English (en)
Inventor
Karl M Gelotte
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603721.3A external-priority patent/GB9603721D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CY2292B1 publication Critical patent/CY2292B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY0200051A 1995-10-27 2002-08-23 Pharmaceutical compositions containing platelet aggregation inhibitors CY2292B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US590795P 1995-10-27 1995-10-27
GBGB9603721.3A GB9603721D0 (en) 1996-02-22 1996-02-22 Composition for inhibiting platelet aggregation

Publications (1)

Publication Number Publication Date
CY2292B1 true CY2292B1 (en) 2003-07-04

Family

ID=26308777

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0200051A CY2292B1 (en) 1995-10-27 2002-08-23 Pharmaceutical compositions containing platelet aggregation inhibitors

Country Status (35)

Country Link
EP (1) EP0859634B1 (xx)
JP (1) JP3452367B2 (xx)
KR (1) KR100362799B1 (xx)
CN (1) CN1158107C (xx)
AT (1) ATE213648T1 (xx)
AU (1) AU712755B2 (xx)
BG (1) BG63623B1 (xx)
BR (1) BR9610878A (xx)
CA (1) CA2234364C (xx)
CO (1) CO4770960A1 (xx)
CY (1) CY2292B1 (xx)
CZ (1) CZ290381B6 (xx)
DE (1) DE69619540T2 (xx)
DK (1) DK0859634T3 (xx)
DZ (1) DZ2110A1 (xx)
EA (1) EA000628B1 (xx)
EE (1) EE03518B1 (xx)
ES (1) ES2171749T3 (xx)
HK (1) HK1017846A1 (xx)
HU (1) HU228757B1 (xx)
IL (1) IL123790A (xx)
IS (1) IS1948B (xx)
MX (1) MX9803275A (xx)
MY (1) MY116837A (xx)
NO (1) NO324415B1 (xx)
NZ (1) NZ323134A (xx)
PL (1) PL185744B1 (xx)
PT (1) PT859634E (xx)
SA (1) SA96170527B1 (xx)
SI (1) SI0859634T1 (xx)
SK (1) SK282353B6 (xx)
TR (1) TR199800716T2 (xx)
TW (1) TW385248B (xx)
UA (1) UA45423C2 (xx)
WO (1) WO1997015328A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ633900A0 (en) 2000-03-20 2000-04-15 Jurox Pty Ltd Anaesthetic composition
CN1322863C (zh) * 2004-10-29 2007-06-27 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射液及其制备方法
CN100386079C (zh) * 2005-03-24 2008-05-07 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射用粉针及其制备方法
CN100367961C (zh) * 2005-09-30 2008-02-13 天津南开允公医药科技有限公司 盐酸替罗非班冻干粉针注射剂及其制备方法
CN102125519B (zh) * 2011-02-28 2012-07-11 正大青春宝药业有限公司 稳定的盐酸替罗非班注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931441A (en) * 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
IL123790A0 (en) 1998-10-30
CA2234364A1 (en) 1997-05-01
BG63623B1 (bg) 2002-07-31
UA45423C2 (uk) 2002-04-15
DE69619540D1 (de) 2002-04-04
CN1200676A (zh) 1998-12-02
EP0859634A1 (en) 1998-08-26
MX9803275A (es) 1998-09-30
IS1948B (is) 2004-10-13
NO324415B1 (no) 2007-10-08
EP0859634B1 (en) 2002-02-27
EA000628B1 (ru) 1999-12-29
IS4699A (is) 1998-03-24
CN1158107C (zh) 2004-07-21
DK0859634T3 (da) 2002-03-25
HUP9902521A3 (en) 2000-01-28
NO981869D0 (no) 1998-04-24
IL123790A (en) 2001-11-25
ATE213648T1 (de) 2002-03-15
PL185744B1 (pl) 2003-07-31
PT859634E (pt) 2002-07-31
HUP9902521A2 (hu) 1999-12-28
CO4770960A1 (es) 1999-04-30
CA2234364C (en) 2000-02-08
NO981869L (no) 1998-04-24
WO1997015328A1 (en) 1997-05-01
KR100362799B1 (ko) 2003-07-16
NZ323134A (en) 1999-11-29
SA96170527B1 (ar) 2005-12-21
TW385248B (en) 2000-03-21
EE03518B1 (et) 2001-10-15
KR19990067020A (ko) 1999-08-16
SK282353B6 (sk) 2002-01-07
BR9610878A (pt) 1999-07-13
DZ2110A1 (fr) 2002-07-22
BG102405A (en) 1999-08-31
EA199800336A1 (ru) 1998-10-29
CZ127898A3 (cs) 1998-10-14
DE69619540T2 (de) 2002-08-22
EE9800134A (et) 1998-10-15
ES2171749T3 (es) 2002-09-16
AU712755B2 (en) 1999-11-18
JPH10512296A (ja) 1998-11-24
AU7718996A (en) 1997-05-15
SK51298A3 (en) 1998-12-02
CZ290381B6 (cs) 2002-07-17
JP3452367B2 (ja) 2003-09-29
SI0859634T1 (en) 2002-04-30
PL326419A1 (en) 1998-09-14
MY116837A (en) 2004-04-30
TR199800716T2 (xx) 1998-07-21
HK1017846A1 (en) 1999-12-03
HU228757B1 (en) 2013-05-28

Similar Documents

Publication Publication Date Title
HK1075197A1 (en) New composition containing taxane derivatives as major component
MY115975A (en) Lactams
GB1520197A (en) Stable antibiotic compositions
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
BR9911300A (pt) Composto, composição farmacêutica, e, uso do composto
CY2292B1 (en) Pharmaceutical compositions containing platelet aggregation inhibitors
HUP9800631A2 (hu) 4-Amino-tetrahidrobenzizoxazol- és 4-amino-tetrahidrobenzizotiazol-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására
IL99898A0 (en) 7-acyl-3-substituted carbamoyloxy cephem compounds,their preparation and antibacterial compositions containing them
AP9901567A0 (en) Steroids substituted in composition 11, their preparation process, their use as medicaments and the pharmaceutical compounds containing them.
IL71068A (en) N-(3-trifluoromethylphenyl)-n'-propargyl-piperazine,its preparation and pharmaceutical compositions containing it
ES8306758A1 (es) Un procedimiento para la preparacion de un derivado de beta-lactama.
GB1549074A (en) Oral compositions containing trifluoromethyl phenyl bis-biguanides as antiplaque agents
TW325469B (en) 5,6-Dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes
ES8507524A1 (es) Un procedimiento para preparar derivados de tropona
IL114646A (en) Pharmaceutical compositions containing phenylurea derivatives for inhibiting leukotriene biosynthesis
GB1464082A (en) Pharmaceutical 'ompositions containing benzylamines
ES8404343A1 (es) Un procedimiento para la prepracion de nuevos derivados de 1,4-diaminociclitol.
ES8302670A1 (es) Procedimiento de preparacion de nuevos derivados 2-hidroxi- metil-quinoxalino-1,4-dioxidos
TH8005B (th) องค์ประกอบสำหรับใช้ทางปาก (Oral Composition)
GB1449441A (en) Agnets for lowering the lipid level in plasma
GB1463965A (en) Pharmaceutical compositions containing benzylamines
GB1414938A (en) 6-aza-1,2-dihydro-3h-1,4-benzodiazepines
GB1267282A (en) Pharmaceutical compositions containing coumermycin derivatives
GB1384441A (en) Benzomorphan derivatives